Wed, January 4, 2023

Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $20 on, Jan 4th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-20-on-jan-4th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Robert Burns of HC Wainwright & Co., Maintained "ADC Therapeutics SA" (ADCT) at Strong Buy with Decreased Target from $21 to $20 on, Jan 4th, 2023.

Robert has made no other calls on ADCT in the last 4 months.



There are 4 other peers that have a rating on ADCT. Out of the 4 peers that are also analyzing ADCT, 2 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $7 on, Monday, November 14th, 2022
  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $7 on, Wednesday, November 9th, 2022


These are the ratings of the 2 analyists that currently disagree with Robert


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $20 on, Wednesday, November 9th, 2022
  • Brian Cheng of "JP Morgan" Initiated at Buy and Held Target at $5 on, Wednesday, September 21st, 2022